Crawford Forrest W, Khayal Inas S, McGue Colleen, Saraswathy Suja, Pirzkall Andrea, Cha Soonmee, Lamborn Kathleen R, Chang Susan M, Berger Mitchel S, Nelson Sarah J
Department of Radiology, University of California-San Francisco, 1700 4th Street, San Francisco, CA 94143-2532, USA.
J Neurooncol. 2009 Feb;91(3):337-51. doi: 10.1007/s11060-008-9719-x. Epub 2008 Nov 15.
Glioblastoma Multiforme (GBM) are heterogeneous lesions, both in terms of their appearance on anatomic images and their response to therapy. The goal of this study was to evaluate the prognostic value of parameters derived from physiological and metabolic images of these lesions. Fifty-six patients with GBM were scanned immediately before surgical resection using conventional anatomical MR imaging and, where possible, perfusion-weighted imaging, diffusion-weighted imaging, and proton MR spectroscopic imaging. The median survival time was 517 days, with 15 patients censored. Absolute anatomic lesion volumes were not associated with survival but patients for whom the combined volume of contrast enhancement and necrosis was a large percentage of the T2 hyperintense lesion had relatively poor survival. Other volumetric parameters linked with less favorable survival were the volume of the region with elevated choline to N-acetylaspartate index (CNI) and the volume within the T2 lesion that had apparent diffusion coefficient (ADC) less than 1.5 times that in white matter. Intensity parameters associated with survival were the maximum and the sum of levels of lactate and of lipid within the CNI lesion, as well as the magnitude of the 10th percentile of the normalized ADC within the contrast-enhancing lesion. Patients whose imaging parameters indicating that lesions with a relatively large percentage with breakdown of the blood brain barrier or necrosis, large regions with abnormal metabolism or areas with restricted diffusion have relatively poor survival. These parameters may provide useful information for predicting outcome and for the stratification of patients into high or low risk groups for clinical trials.
多形性胶质母细胞瘤(GBM)是一种异质性病变,无论是在解剖图像上的表现还是对治疗的反应方面。本研究的目的是评估从这些病变的生理和代谢图像中得出的参数的预后价值。56例GBM患者在手术切除前立即接受了传统解剖磁共振成像扫描,并在可能的情况下接受了灌注加权成像、扩散加权成像和质子磁共振波谱成像。中位生存时间为517天,有15例患者失访。绝对解剖病变体积与生存无关,但对比增强和坏死的总体积占T2高信号病变的比例较大的患者生存相对较差。与生存较差相关的其他体积参数包括胆碱与N-乙酰天门冬氨酸指数(CNI)升高区域的体积以及T2病变内表观扩散系数(ADC)小于白质中ADC 1.5倍的区域的体积。与生存相关的强度参数包括CNI病变内乳酸和脂质水平的最大值及总和,以及对比增强病变内归一化ADC第10百分位数的大小。成像参数表明血脑屏障破坏或坏死比例相对较大、代谢异常区域较大或扩散受限区域较大的病变的患者生存相对较差。这些参数可能为预测预后以及将患者分层为临床试验的高风险或低风险组提供有用信息。